Kinea Bio Revenue and Competitors
Estimated Revenue & Valuation
- Kinea Bio's estimated annual revenue is currently $1.4M per year.
- Kinea Bio's estimated revenue per employee is $155,000
Employee Data
- Kinea Bio has 9 Employees.
- Kinea Bio grew their employee count by 29% last year.
Kinea Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Operations | Reveal Email/Phone |
2 | Director Operations | Reveal Email/Phone |
Kinea Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Kinea Bio?
Kinea Bio is a patient-focused biotechnology company striving to accelerate the development of next-generation AAV-based gene therapies to treat neuromuscular diseases. Kinea is developing an integrated technology platform designed to address the most critical challenges facing the field of gene therapy, including novel targeting and gene regulation technologies, advanced engineered tissue modeling capabilities, and strategies that will enable delivery of larger, more functional therapeutic cargos that has previously been possible.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 9 | 50% | N/A |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.7M | 9 | N/A | N/A |
